New Product Development Process In The Generic Pharmaceutical Industry / (Record no. 8882)

MARC details
000 -LEADER
fixed length control field 05944nam a22002537a 4500
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 210203b2019 a|||f mb|| 00| 0 eng d
040 ## - CATALOGING SOURCE
Original cataloging agency EG-CaNU
Transcribing agency EG-CaNU
041 0# - Language Code
Language code of text eng
Language code of abstract eng
082 ## - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 658.4
100 0# - MAIN ENTRY--PERSONAL NAME
Personal name Michael Nabil Hanna
245 1# - TITLE STATEMENT
Title New Product Development Process In The Generic Pharmaceutical Industry /
Statement of responsibility, etc. Michael Nabil Hanna
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Date of publication, distribution, etc. 2019
300 ## - PHYSICAL DESCRIPTION
Extent 132 p.
Other physical details ill.
Dimensions 21 cm.
500 ## - GENERAL NOTE
Materials specified Supervisor: Mohamed Awny
502 ## - Dissertation Note
Dissertation type Thesis (M.A.)—Nile University, Egypt, 2019 .
504 ## - Bibliography
Bibliography "Includes bibliographical references"
505 0# - Contents
Formatted contents note Contents:<br/>CHAPTER (1): INTRODUCTION. ………………………………..…………<br/>1<br/>1.1. Overview. ………………………………..………………...………<br/>2<br/>1.2. Problem statement. ……………………………………….………...<br/>3<br/>CHAPTER (2): The new products development process. ……………...………...<br/>4 2.1. Introduction. ……………………………..………….……...………<br/>5 2.2. Product Innovation Management………………….…………..……<br/>9 2.3. Different NPD evaluation models………………….……………….<br/>11 2.4. Assessing NPD maturity level………………………..……..………<br/>13 2.5. Innovation Metrics………………………………….……………….<br/>14 2.6. Design for Six Sigma (DFSS) & Quality by Design (QbD)……..….<br/>18<br/>CHAPTER (3): THE PROBLEM, OBJECTIVES, AND METHODOLOGY…..<br/>22 3.1. Problem statement…………………………………………………..<br/>23 3.2. Objectives of this Master Project……………………………………<br/>23 3.3. Research questions………………………………………………….<br/>23 3.4. Methodology. …………………………….………………………... 24 CHAPTER (4): THE CASE STUDY…………….………………………………<br/>25 4.1. Generic Pharmaceutical Industry in Egypt……………….………...<br/>26 4.1.1. Company profile………………………….…………..…….<br/>29 4.1.2. Markets. ……………………………..……………………..<br/>30 4.1.3. Strategy. ……………………………………………..…….<br/>30<br/>IV<br/>4.1.4. Cross-functional team structure………………..…………..<br/>31 4.2. New Products development process in E.P…………………………<br/>31<br/>CHAPTER (5): THE BUILD UP OF RESEARCH SURVEY………………..<br/>33 5.1. Research design…………………………………………………….<br/>34 5.1.1. Research Instrument……………………………….………<br/>34<br/>CHAPTER (6): RESEARCH RESULTS AND ANALYSIS……………….….<br/>42 6.1. Assessment Process………………………………………..……….<br/>43 6.1.1. Level 1: Overall NPD Index…………………….………..<br/>43 6.1.2. Level 2: The four major best practice categories…………<br/>43 6.1.3. Level 3: Sub-sections of the four major categories………<br/>43 6.1.4. Level 4: Individual questions in the survey………….……<br/>43 6.2. Sample Size Determination………………………………….….….<br/>43 6.3. Data Representation………………………………………..………<br/>44 6.4. Data Analysis………………………………………….…..……….<br/>46 6.4.1. Regression Models………………….……….…..….…….<br/>47 6.4.1.1. Infrastructure. …………………………..……..<br/>47 6.4.1.2. Management. ………………………….………<br/>49 6.4.1.3. Metrics. ……………………..………..……….<br/>50 6.4.1.4. Teams & Resources…………………….……..<br/>52 6.5. Data Interpretation………………………………………….……..<br/>53<br/>CHAPTER (7): DISCUSSIONS, CONCLUSIONS AND RECOMMENDATIONS…<br/>54 7.1. Discussion. ………………………………………………….…….<br/>55 7.2. Conclusions. …………………………………………..…….…….<br/>56 7.3. Recommendations. ……………………………………….……….<br/>57 7.4. Future implications. …
520 3# - Abstract
Abstract Abstract:<br/>New products development process (NPD) is highly affecting the economic growth especially in innovative industries like the pharmaceutical industry. NPD affects the speed of introducing new products to the market which is a key competitive advantage for firms. This project is focusing on the new products development process (NPD) in the generic pharmaceutical industry, as it contributes to the future of the company and subsequently the future of the industry. The objective of this project is to identify the main areas of improving new products development process in the generic pharmaceutical industry as applied to Egypt. This research focuses on the real case of an Egyptian Pharmaceutical company as the field study. A survey is carried out to assess the practices of NPD within one of the top ten pharmaceutical manufacturing companies in Egypt that adopted a new products development process. The outcome of this research is the identification of the main issues affecting the NPD process. Four aspects affecting NPD process were surveyed (Teams & resources, Infra-structure, Management, Metrics). By analysis, “Teams & resources” and “Infra-structure “ aspects were found to be the categories most affecting NPD process. This outcome will help management to put an action plan to cover the most important aspects and identify the best practices to be adopted in the pharmaceutical industry. Major recommendations include the solid implementation of project management tools and tactics in NPD. In addition to the empowerment of cross-functional teams with best practices to ensure team autonomy.
546 ## - Language Note
Language Note Text in English, abstracts in English.
650 #4 - Subject
Subject MOT
655 #7 - Index Term-Genre/Form
Source of term NULIB
focus term Dissertation, Academic
690 ## - Subject
School MOT
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme Dewey Decimal Classification
Koha item type Thesis
650 #4 - Subject
-- 309
655 #7 - Index Term-Genre/Form
-- 187
690 ## - Subject
-- 309
Holdings
Withdrawn status Lost status Source of classification or shelving scheme Damaged status Not for loan Home library Current library Date acquired Total Checkouts Full call number Date last seen Price effective from Koha item type
    Dewey Decimal Classification     Main library Main library 02/03/2021   658.4 / M.N.N 02/03/2021 02/03/2021 Thesis